失眠的认知行为疗法可能改善克罗恩病的睡眠和疼痛:等候名单控制试点试验
Jessica K Salwen-Deremer1,2, Sarah J Westvold3, Kelly Aschbrenner1,4
1Department of Psychiatry, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States.
Inflammatory bowel diseases
|September 25, 2025
概括
不眠症的认知行为疗法 (CBT-I) 显著改善了克罗恩病患者的睡眠质量并减少了疼痛. 这种疗法为管理睡眠障碍和炎症性肠病相关症状提供了一个有前途的方法.
科学领域:
- 胃肠病学 胃肠病学
- 睡眠医学 睡眠医学
- 精神病学是一个精神病学.
背景情况:
- 睡眠不足和失眠在克罗恩病 (CD) 中很普遍,通常预测疾病轨迹会更糟.
- 失眠的认知行为疗法 (CBT-I) 是治疗慢性失眠的黄金标准,可以积极影响疼痛和炎症.
研究的目的:
- 评估CBT-I在改善活跃克罗恩病患者睡眠,疼痛和炎症方面的疗效.
- 研究CBT-I对主观和客观睡眠,疼痛强度,疼痛干扰和C反应性蛋白水平的影响.
主要方法:
- 一项随机对照试验,涉及26名患有轻度至中度CD和失眠的患者.
- 参与者被随机分配到接受即时的CBT-I或12周的等待名单,然后对睡眠,疼痛和炎症进行评估.
- CBT-I干预包括睡眠限制,刺激控制,睡眠卫生,兴奋减缓和认知疗法.
主要成果:
- 与等候名单组相比,CBT-I显著降低了失眠的严重程度,并在睡眠开始后醒来.
- 患者在治疗后报告了睡眠连续性,CD症状严重程度,疼痛强度和疼痛干扰的显著改善.
- C-反应蛋白水平呈现出改善的趋势,这表明潜在的抗炎作用.
结论:
- 这项研究提供了初步证据,支持CBT-I对克罗恩病患者的有效性.
- CBT-I证明了对自我报告的睡眠,疼痛和CD症状的潜在益处,强调了在IBD管理中解决睡眠问题的重要性.
- 建议使用更大的样本大小进行进一步的研究,以确认CBT-I对CD患者疼痛和炎症的影响.
相关概念视频
01:19Management of Insomnia
542
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
542
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
493
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
493
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
437
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
437
01:27Insomnia
410
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
410
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
492
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
492
01:21Drugs for Treatment of Constipation-Predominant IBS
724
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
724